S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden’s $374B Giveaway Into This Sector (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden’s $374B Giveaway Into This Sector (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden’s $374B Giveaway Into This Sector (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden’s $374B Giveaway Into This Sector (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
OTCMKTS:EPGNY

Epigenomics (EPGNY) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)
Free EPGNY Stock Alerts
$2.39
0.00 (0.00%)
(As of 04/6/2023)
Compare
Today's Range
$2.39
▼
$2.39
50-Day Range
$2.39
▼
$2.39
52-Week Range
$2.01
▼
$2.39
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
EPGNY stock logo

About Epigenomics Stock (OTCMKTS:EPGNY)

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

EPGNY Stock Price History

EPGNY Stock News Headlines

March 14, 2024 | markets.businessinsider.com
EQS-News: Epigenomics AG publishes financial results for fiscal year 2023
January 31, 2024 | markets.businessinsider.com
EQS-News: Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
April 18, 2024 | DTI (Ad)
Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
October 10, 2023 | markets.businessinsider.com
EQS-Adhoc: Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023
October 10, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023
September 20, 2023 | finance.yahoo.com
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
September 14, 2023 | benzinga.com
New Day Diagnostics Announces Approval of Purchase Agreement by Epigenomics' AG Extraordinary General Meeting
August 10, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG publishes financial results for the first six months 2023
April 18, 2024 | DTI (Ad)
Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
July 24, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
July 24, 2023 | finance.yahoo.com
New Day Diagnostics LLC Reinforces Commitment to Early Cancer Intervention with Its intention to Acquire the Assets of Epigenomics AG
July 3, 2023 | finance.yahoo.com
Estimating The Intrinsic Value Of Epigenomics AG (ETR:ECX1)
June 12, 2023 | marketwatch.com
Epigenomics Shares Surge on Talks to Sell Nearly All Assets for $11.5 Mln
May 19, 2023 | uk.news.yahoo.com
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
May 19, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
April 13, 2023 | uk.finance.yahoo.com
Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
April 12, 2023 | markets.businessinsider.com
EQS-Adhoc: Epigenomics AG: Changes in the Management
April 12, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
March 20, 2023 | uk.finance.yahoo.com
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
March 14, 2023 | benzinga.com
Sample Preparation in Genomics, Proteomics, and Epigenomics Global Market Report 2023: Increased R&D Spending in Developing Economies Boosts Sector
March 10, 2023 | uk.finance.yahoo.com
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
February 21, 2023 | marketwatch.com
Personalized Medicine and Epigenomics Market Capitalizing on Market Growth: Essential Insights from Our Latest Research Report
January 27, 2023 | uk.finance.yahoo.com
Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
January 27, 2023 | markets.businessinsider.com
EQS-News: Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski
December 23, 2022 | markets.businessinsider.com
EQS-News: Pareto Securities AS publishes buy recommendation for Epigenomics AG share
December 21, 2022 | markets.businessinsider.com
EQS-Adhoc: Epigenomics AG: Further raise of earnings guidance for the current fiscal year 2022
December 14, 2022 | markets.businessinsider.com
EQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
See More Headlines
Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:EPGNY
CUSIP
N/A
CIK
N/A
Web
www.epigenomics.com
Phone
(493) 024-3450
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Gregory K. Hamilton (Age 52)
    CEO & Member of the Exec. Board
    Comp: $828.44k
  • Dr. Andrew A. Lukowiak Ph.D. (Age 50)
    Pres & Chief Scientific Officer
    Comp: $387.44k
  • Mr. Jens Ravens (Age 52)
    CFO & Member of Exec. Board
  • Frederic Hilke
    Investor Relations Officer
  • Dr. Noel Thomas Doheny
    Chief Exec. Officer of Epigenomics Inc.

Key Competitors

View All Competitors

EPGNY Stock Analysis - Frequently Asked Questions

How have EPGNY shares performed in 2024?

Epigenomics' stock was trading at $2.39 at the beginning of 2024. Since then, EPGNY shares have increased by 0.0% and is now trading at $2.39.
View the best growth stocks for 2024 here.

How do I buy shares of Epigenomics?

Shares of EPGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EPGNY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends